Alyssa’s Story
Find out more about how Cure Leukaemia's funding impacts patients in Blackpool and surrounding areas
Cure Leukaemia is proud to play a vital role in supporting blood cancer patients across Blackpool and Cumbria, through a vital partnership between Blackpool Teaching Hospitals and Booths Supermarkets. The partnership see’s Booths raise a minimum of £50,000 each year through a range of fundraising initiatives to benefit blood cancer patients across Lancashire and Cumbria, to fund a Cure Leukaemia Research Nurse in the region, who ensures patients have access to pioneering treatments and potentially life-saving clinical trials.
Together, these efforts help to provide hope, innovation, and improved outcomes for people facing blood cancer across the region.
Discover which clinical trials have been delivered in Blackpool, with support of funding from Cure Leukaemia
The VICTOR trial is a groundbreaking clinical trial available at TAP Centres across the UK, comparing a combination of two targeted drugs to traditional chemotherapy. This trial, specifically designed for AML patients aged 60 and over, offered a less toxic and more manageable treatment option.
Focused on patients with Myelofibrosis, the Fedora trial is tackling a critical area of unmet need, gathering information about whether a combination of treatments is tolerated, and whether it provides a therapeutic benefit to patients. The FEDORA Trial has now completed recruitment, with results expected to be published soon.
One of the TAP Network’s highest recruiting studies, AMMO trial tests a new drug in treating and extending the lives of patients with a rare bone marrow cancer, where treatment options are very limited. The treatment can be taken orally at home, making it much more convenient for patients. The trial has just concluded and results are expected to be published at the end of 2025.
Alyssa’s Story
Hughie’s Story
Kathryn’s Story
Austin’s Story
James’ Story
Adam’s Story
Jude’s Story